Expression of the caspase-8 gene in neuroblastoma cells is regulated through an essential interferon-sensitive response element (ISRE)

Cell Death and Differentiation

Volumn 11, Issue 1, 2004, Pages 131-134

  Casciano, I ^a   De Ambrosis, A ^a   Croce, M ^a   Pagnan, G ^b   Di Vinci, A ^a   Allemanni, G ^a   Banelli, B ^a   Ponzoni, M ^b   Romani, M ^a   Ferrini, Silvano ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; COMPLEMENTARY DNA; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT1 PROTEIN;

CANONICAL ANALYSIS; COMPUTER ANALYSIS; DNA RESPONSIVE ELEMENT; E BOX ELEMENT; GENE EXPRESSION REGULATION; HUMAN; LETTER; NEUROBLASTOMA CELL; NUCLEIC ACID IMMOBILIZATION; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION SITE; UPREGULATION;

CASPASE 8; CASPASES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERFERON REGULATORY FACTOR-1; INTERFERONS; NEUROBLASTOMA; PHOSPHOPROTEINS; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 1642514756     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401327     Document Type: Letter

References (30)

1. Tamm I et al. (2001) Lancet Oncol. 2: 33-42
2. Fischer U et al. (2003) Cell Death Differ. 10: 76-100
3. Nunez G et al. (1998) Oncogene 17: 3237-3245
4. Muzio M et al. (1996) Cell 85: 817-827
5. Boldin MP et al. (1996) Cell 85: 803-815
6. LeBlanc HN and Ashkenazi A (2003) Cell Death Differ. 10: 66-75
7. Peter ME and Krammer PH (2003) Cell Death Differ. 10: 26-35
8. Eggert A et al. (2001) Cancer Res. 61: 1314-1319
9. Fulda S et al. (2001) Oncogene 20: 5865-5877
10. Teitz T et al. (2000) Nat. Med. 6: 529-535
11. Annicchiarico-Petruzzelli M (2001) Med. Pediatr. Oncol. 36: 115-117
12. Fulda S and Debatin KM (2002) Oncogene 21: 2295-2308
13. Yang X et al. (2003) Cancer Res. 63: 1122-1129
14. Banelli B et al. (2002) Nat. Med. 8: 1333-1335
15. Ramana CV et al. (2000) Oncogene 19: 2619-2627
16. Muhlethaler-Mottet A et al. (1997) EMBO J. 16: 2851-2860
17. Storm van's Gravesande K et al. (2002) J. Immunol. 168: 4488-4494
18. Tanaka N et al. (1993) Mol. Cell. Biol. 13: 4531-4538
19. Decker T et al. (1997) J. Interferon Cytokine Res. 17: 121-134
20. Liedtke C et al. (2003) J. Biol. Chem. 278: 27593-27604
21. Refaeli Y et al. (2002) J. Exp. Med. 196: 999-1005
22. Fernandes-Alnemri T et al. (1996) Proc. Natl. Acad. Sci. USA 93: 7464-7469
23. Himeji D et al. (2002) Blood 99: 4070-4078
24. Xi H and Blanck G (2003) Mol. Immunol. 39: 677-684
25. Blanco JC et al. (2000) J. Exp. Med. 191: 2131-2144
26. Falvo JV et al. (1995) Cell 83: 1101-1111
27. Thanos D and Maniatis T (1995) Cell 83: 1091-1100
28. Muhlethaler-Mottet A et al. (1998) Immunity 8: 157-166
29. Gongora C et al. (2000) Nucleic Acids Res. 28: 2333-2341
30. Boyd KE et al. (1998) Proc. Natl. Acad. Sci. USA 95: 13887-13892